Lv1
98 积分 2022-08-12 加入
Crohn's disease
11天前
已完结
RISANKIZUMAB IMPROVES SYMPTOMS IN ADULTS WITH CROHN'S DISEASE IN CLINICAL PRACTICE: INITIAL RESULTS FROM THE ASPIRECD STUDY
29天前
已关闭
MID-TERM OUTCOMES OF RISANKIZUMAB IN REFRACTORY CROHN'S DISEASE: A MULTICENTER REAL-WORLD STUDY IN ANDALUSIA, SPAIN
29天前
已完结
REAL-WORLD EFFECTIVENESS OF RISANKIZUMAB IN ACHIEVING EARLY TRANSMURAL HEALING IN CROHN'S DISEASE: A PROSPECTIVE SINGLE-CENTER EXPERIENCE
1个月前
已关闭
Therapeutic Efficacy of Risankizumab for Small-Intestinal Lesions in Crohn's Disease: A Retrospective Study Using Double-Balloon Endoscopy
1个月前
已关闭
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB AS INDUCTION THERAPY FOR CROHN'S DISEASE
1个月前
已关闭
Therapeutic Efficacy of Risankizumab for Small-Intestinal Lesions in Crohn's Disease: A Retrospective Study Using Double-Balloon Endoscopy
1个月前
已关闭
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study
1个月前
已完结
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease
1个月前
已完结
皖公网安备34019202002308
